Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
An excipient is defined as any substance, other than the active pharmaceutical ingredient (API), that is intentionally included in a drug delivery system to facilitate manufacturing, protect the API, or enhance product performance (NIH) [2, 4]. These substances serve diverse functional roles, including acting as binders, disintegrants, lubricants, and preservatives, which are essential for creating stable and effective dosage forms such as tablets or injections (Wikipedia) [6]. While historically classified as pharmacologically inert, modern research has demonstrated that many excipients possess bioactivity and can influence a drug's pharmacokinetics by modulating transporters or metabolic enzymes (PMC) [10]. Excipients are critical for improving the solubility and bioavailability of poorly water-soluble drugs and can be engineered for targeted or controlled drug release (ScienceDirect) [1, 5]. Despite their biological influence on drug absorption and safety, they are not considered therapeutic targets in the context of drug discovery; rather, they are strategic components of the pharmaceutical formulation intended to optimize the delivery of the primary therapeutic agent (Colorcon) [11]. Biopharmaceutical analysts must consider excipient selection carefully, as interactions between these 'inactive' ingredients and the biological milieu can impact the overall clinical efficacy and safety profile of a medication (MDPI) [7, 8].
Not applicable; excipients are auxiliary substances in drug formulations and do not serve as therapeutic targets for other drugs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Excipient.